6,265,540
US
5/19/1998
7/24/2001
5/19/2018
Tissue specific prodrug (PSA)
6,410,514
US
6/7/2000
6/25/2002
5/20/2018
Tissue specific prodrug (PSA)
6,504,014
US
6/7/2000
1/7/2003
5/19/2018
Tissue specific prodrug (PSA)
6,545,131
US
7/28/2000
4/8/2003
5/19/2018
Tissue specific prodrug (PSA)
7,053,042
US
7/28/2000
5/30/2006
1/4/2023
Activation of peptide prodrugs by HK2
7,468,354
US
11/30/2001
12/23/2008
11/24/2023
Tissue specific prodrug (G-202, PSMA)
7,635,682
US
1/6/2006
12/22/2009
5/19/2018
Tumor activated prodrugs (G-115)
7,767,648
US
11/25/2008
8/3/2010
1/20/2022
Tissue specific prodrug (G-202, PSMA)
7,906,477
US
11/18/2003
3/15/2011
9/20/2026
Activation of peptide prodrugs by HK2
US 2010/0120697
US
11/5/2009
Pending
N/A
Tumor activated prodrugs (PSA, G-115)
PCT/US2010/027657
PCT
3/17/2010
Pending
N/A
Methods and compositions for the detection of cancer
US 2011/0245147
US
1/10/2011
Pending
N/A
Activation of peptide prodrugs by HK2
